SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-18-274146
Filing Date
2018-09-14
Accepted
2018-09-14 16:06:29
Documents
13
Period of Report
2018-09-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A d610922dpre14a.htm PRE 14A 692722
2 GRAPHIC g610922001.jpg GRAPHIC 42419
3 GRAPHIC g610922002.jpg GRAPHIC 45203
4 GRAPHIC g610922003.jpg GRAPHIC 7303
5 GRAPHIC g610922004.jpg GRAPHIC 16246
6 GRAPHIC g610922005.jpg GRAPHIC 33045
7 GRAPHIC g610922g1010064728129.jpg GRAPHIC 677
8 GRAPHIC g610922g1010064728207.jpg GRAPHIC 782
9 GRAPHIC g610922g1010064728894.jpg GRAPHIC 734
10 GRAPHIC g610922g17z11.jpg GRAPHIC 977
11 GRAPHIC g610922g69c02.jpg GRAPHIC 924
12 GRAPHIC g610922g83x45.jpg GRAPHIC 844
13 GRAPHIC g610922g91p42.jpg GRAPHIC 8302
  Complete submission text file 0001193125-18-274146.txt   912482
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: PRE 14A | Act: 34 | File No.: 000-50484 | Film No.: 181071194
SIC: 2834 Pharmaceutical Preparations